[시장보고서]세계의 임상 검사 서비스 시장 : 제10판

세계의 임상 검사 서비스 시장 : 제10판

Worldwide Market for Clinical Laboratory Services, 10th Edition

상품코드 : 1785094

리서치사 : Kalorama Information

발행일 : 2025년 08월

페이지 정보 : 영문 270 pages

라이선스 & 가격 (부가세 별도)

한글목차

샘플 요청 목록에 추가

'세계의 임상 검사 서비스 시장 제10판'은 세계 임상 검사 서비스 산업의 결정적인 분석을 제공하며 2024-2029년 시장 규모, 성장 촉진요인, 수요가 있는 검사 유형, 경쟁 포지셔닝에 대한 경쟁 인사이트을 제공합니다. 이 보고서는 COVID-19의 유행 상태로의 전환과 관련된 진단 서비스의 역학을 이해하려는 이해 관계자에게 중요한 자료입니다.

IVD 제조업체에게 보고서가 필수적인 이유

Kalorama Information의 이 연례 검토는 체외 진단용 의약품 제조업체에게 필수적입니다. 임상 검사실은 체외진단제(IVD) 시장의 핵심이며, 유전병과 감염증에서 만성 질환과 종양에 이르기까지 다양한 질병의 진단, 모니터링, 치료에 필수적인 지견을 제공합니다. 임상 진단의 70-80%는 실험실 검사로 인한 것이며, 이러한 서비스는 현대 건강 관리 제공에 필수적입니다.

실험실 서비스 시장 기회 제10판

이 보고서의 제10판은 세계의 검사 수요를 형성하는 개발에 중점을 두고 임상 검사의 현재 상태를 자세히 평가합니다. 과거 시장 동향에서 현재 및 예측 데이터에 이르기까지, 이 보고서는 기업이 실적을 벤치마킹하고 향후 전환에 대비하도록 도와줍니다.

이 보고서의 주요 특징

업계 개요 : 역사적 뿌리, 헬스케어에서의 역할 진화, 외래 및 원격 검사에 대한 의존성 증가와 같은 임상 검사 부서를 자세히 설명합니다.
영향력 있는 통계 : 인구 역학 변화, 질병 발생 동향, 평균 수명 및 임상 검사 업계에 영향을 미치는 광범위한 헬스케어 환경을 분석합니다.
세계적 포커스 : 지역별 분석
- 북미(미국, 캐나다)
- EMEA(독일, 프랑스, 이탈리아, 스페인, 영국, 스위스)
- 아시아태평양(일본, 중국, 인도, 한국, 호주)
- 라틴아메리카(브라질, 멕시코)

대상 전문 분야

필수 및 루틴 검사 : 임상 화학, 혈액학, 응고학, 내분비학
면역학 및 미생물학 검사
세포학 및 조직학 검사
유전자 검사
독물학 검사(남용 약물)
COVID-19 검사

시험소 유형별 시장 세분화

독립계 검사기관 및 기준검사기관
병원 기반 검사실
클리닉 기반 검사 기관

경쟁 분석 :

본 보고서에서는 임상 검사 서비스 제공업체 각사 시장 전략, 지역별 강점, 의료 제공 모델 및 상환 구조의 변화에 대응한 조정에 대해 상세하게 설명하고 종합적인 경쟁 리뷰를 제공합니다.

데이터 및 예측
기준 연도	2024년
과거 데이터	2019-2024년
예측 기간	2025-2029년
CAGR :	모든 주요 부문에 대해 제공
시장 수준	서비스 제공업체 및 제조업체 수준 수익

과제 및 조정 :

가격 압력, 상환 제도 개혁, 통합 동향, COVID-19의 지속적인 영향 등 업계의 새로운 동향을 반영하기 위해이 보고서의 각 버전은 개정되었습니다. 또한 재택 의료 및 외래 의료에 대한 의존의 고조 등 진단 서비스에 대한 새로운 수요 패턴을 촉진하는 업무 시프트도 고려하고 있습니다.

제외 항목

본 보고서에서는 임상 시험 검사, 동물 실험실, 환경 검사, 검체 채취 및 운송 등 부대 서비스에 의한 수익은 제외하고 있습니다.

세계 경쟁업체 요약
기업 프로파일
ARUP LABORATORIES
BIOREFERENCE HEALTH - AN OPKO HEALTH SUBSIDIARY
DAVITA
EUROFINS SCIENTIFIC SE
EXACT SCIENCES CORP.
GUARDANT HEALTH
HU GROUP HOLDINGS
LABORATORY CORPORATION OF AMERICA
MEDICOVER AB
MYRIAD GENETICS, INC.
NATERA
QUEST DIAGNOSTICS, INC.
SIEMENS HEALTHINEERS
SONIC HEALTHCARE LIMITED
SYNLAB INTERNATIONAL GMBH
UNILABS

제10장 시장 동향 및 요약

세계 시장 개요
지역 개요
- 인구 증가
- 고령화 사회
- 질병 부담의 증대
- 개발도상 지역의 경제 성장
- 선진 지역에서의 경제 안정화
- 가격압력
- 효율적인 의료 시스템에 초점
- 헬스케어 서비스 수요의 전체적 증가
- COVID-19
- 멀티플렉스 검사
- AI 및 머신러닝의 연구실의 동향
- 분자 검사 및 기타 고급 검사가 새로운 길 확장
- 디지털 병리학의 동향
- 인원 부족

AJY

영문 목차

영문목차

"Worldwide Market for Clinical Laboratory Services, 10th Edition" provides a definitive analysis of the global clinical lab services industry, offering critical insights into market size, growth drivers, testing types in demand, and competitive positioning from 2024 to 2029. This report is a key resource for stakeholders seeking to understand diagnostic service dynamics in the wake of COVID-19's transition to endemic status.

Why This Report is Essential for IVD Manufacturers

This annual review by Kalorama Information is indispensable for IVD manufacturers. Clinical laboratories are the core of the in vitro diagnostics (IVD) market, delivering essential insights for diagnosis, monitoring, and treatment across a wide range of conditions-from genetic and infectious diseases to chronic illnesses and oncology. With 70-80% of clinical diagnoses informed by lab tests, these services remain integral to modern healthcare delivery.

Market Opportunity in Lab Services: Now in Its 10th Edition

The 10th edition of this report offers an in-depth assessment of the clinical laboratory landscape, highlighting developments that are shaping global testing demand. From historical market trends to current and forecasted data, the report helps companies benchmark performance and prepare for future shifts.

Key Features of the Report:

Industry Overview: Presents a detailed exploration of the clinical laboratory sector, including its historical roots, evolving role in healthcare, and the growing reliance on outpatient and remote testing.
Influential Statistics: Analyzes demographic shifts, disease incidence trends, life expectancy, and the broader healthcare environment impacting the clinical lab industry.
Global Focus: Regional breakdowns include:
- North America (United States, Canada)
- EMEA (Germany, France, Italy, Spain, United Kingdom, Switzerland)
- Asia Pacific (Japan, China, India, South Korea, Australia)
- Latin America (Brazil, Mexico)

Specialty Segments Covered:

Essential and Routine Testing: Clinical chemistry, hematology, coagulation, and endocrinology
Immunology and Microbiology Testing
Cytology and Histology Testing
Genetic Testing
Toxicology Testing (Drugs of Abuse)
COVID-19 Testing

Market Segmentation by Laboratory Type:

Independent and Reference Laboratories
Hospital-based Laboratories
Clinic-based Laboratories

Competitive Analysis:

The report includes a comprehensive competitive review of top clinical laboratory service providers, detailing their market strategies, regional strengths, and adjustments in response to shifting healthcare delivery models and reimbursement structures.

Data and Forecasting
Base Year:	2024
Historical Data:	2019-2024
Forecast Period:	2025-2029
CAGRs:	Provided for all major segments
Market Level:	Service provider/manufacturer level revenues

Challenges and Adjustments:

Each edition of the report is revised to reflect new industry developments, including pricing pressures, reimbursement reform, consolidation trends, and the continued impact of COVID-19. It also considers operational shifts such as increased reliance on home-based and outpatient care settings, driving new demand patterns for diagnostic services.

Exclusions:

The report excludes revenues from clinical trial testing, veterinary labs, environmental testing, and ancillary services such as specimen collection and transportation.

ABOUT KALORAMA INFORMATION

CHAPTER ONE: EXECUTIVE SUMMARY

INDUSTRY AT A GLANCE
- Figure 1-1: Worldwide Market for Clinical Laboratory Services Snapshot, 2025 (Market Overview, Key Service Providers, World Regions)
SCOPE AND METHODOLOGY
GLOBAL MARKET OVERVIEW
- Figure 1-2: Factors Growing Clinical Lab Demands, 2025
- Table 1-1: Global Clinical Laboratory Market Analysis, 2019-2029 ($ million)
- Figure 1-3: Global Clinical Laboratory Market Analysis, 2019-2029 ($ million)
KEY ISSUES AND TRENDS AFFECTING THE MARKET
LEADING MARKET PARTICIPANTS

CHAPTER TWO: INDUSTRY OVERVIEW

CLINICAL LABORATORY DESCRIPTION
- Figure 2-1: Clinical Labatory Order
- Figure 2-2: Hospital Length of Stay in Days, by Country, 2021 Average (Australia, Austria, Belgium, Canada, Finland, France, Germany, Greece, Hungary, Ireland, Israel, Italy, Japan, Korea, Luxembourg, the Netherlands, Norway, Poland, Portugal, Romania, Slovenia, Spain, Sweden, Switzerland, Turkey, United Kingdom, United States)
- Laboratory Service Payer Types
  - Table 2-1: U.S. Clinical Laboratory Revenues, by Client and Payer Type, 2024 (%) (Commercial Insurance, Managed Care, Medicare and Medicaid, Private Patient)
  - Figure 2-3: Clinical Laboratory Revenues, by Client and Payer Type, Estimated 2024 (%) (Commercial Insurance, Managed Care, Medicare and Medicaid, Private Patient)
NUMBER OF LABORATORY HEALTH WORKERS BY COUNTRY
- Figure 2-4: Laboratory Health Workers, by Country, 2010-2021 Average (Argentina, Australia, Brazil, Canada, China, India, Indonesia, Mexico, Republic of Korea, South Africa, United Kingdom, United States)
THE LARGEST CLINICAL LABORATORY MARKET: THE UNITED STATES
- Structure and Regulation in the U.S.
- Certificate of Waiver
  - Table 2-2: Selected CLIA Waived Laboratory Tests
- Certificate of Provider-Performed Microscopy Procedures (PPMP)
  - Table 2-3: Provider-Performed Microscopy Procedures
- Certificate of Compliance and Certificate of Accreditation
  - Figure 2-5: Clinical Laboratory Certificate of Accreditation Issued by Organization (non-exempt laboratories only), April 2024 (%)
  - Table 2-4: Clinical Laboratory Certificates Issued, by State and by Type (non-exempt laboratories only), as of April 2024
  - Figure 2-6: Laboratory Certificate Trends, by Application Type, July 2010-April 2024 (Accreditation, Compliance, PPM, Waiver)
- States Exempt from Federal Clinical Laboratory Improvements Amendments (CLIA) of 1988
  - Table 2-5: CLIA Exempt States, Number of Laboratories, as of April 2024
LABORATORY DEVELOPED TEST REGULATIONS
- Directive 2017/746 (IVDR)
PAYERS AND REIMBURSEMENT
- Figure 2-7: Positive Forces and Negative Forces Impacting Clinical Laboratory Services, 2025
- Trends in Medicare Reimbursement
  - Figure 2-8: Medicare Reimbursement Trends, Average Reimbursement for Clinical Laboratory Services, 2009 through 2024
- Protecting Access to Medicare Act (PAMA) of 2014
  - Table 2-6: Proposed Clinical Diagnostic Laboratory Test Rates, 2020-2026
- Saving Access to Laboratory Service Act (SALSA)
- Advanced Laboratory Tests (ADLT)
  - Table 2-7: List of Approved ADLTs, March 2025
- Bundled Insurance Payments for ESRD Patients
  - Table 2-8: Laboratory Tests Subject to ESRD Consolidated Billing (CY 2025)
- Commercial Insurance Providers
  - Table 2-9: National Commercial Insurance Provider List Revenues, 2024
  - Figure 2-9: National Commercial Insurance Providers by Membership and Total Revenues, 2024 ($ billion)
TRANSPARENCY IN PRICING
- Figure 2-10: Revenue and Test Volume Trends, Quest Diagnostics, 2010-2024 ($ million) (volume million)
DIRECT-TO-CONSUMER TESTING
- Table 2-10: Select DTC Tests and Prices by Laboratory Service Provider (Quest Direct and Labcorp On Demand), 2023 (US $)
EXPANDING CANCER TEST UTILIZATION AND TECHNOLOGIES
- Labcorp Acquires Select Assets of Invitae
- Labcorp Launches Plasma Detect
- Quest Launches MelaNodal Predict Test
- Labcorp Launches First CDx Assay for Gastric Cancer Patients
- Labcorp Expands Molecular Residual Disease and Liquid Biopsy Solutions
- Quest Develops Multi-Cancer Stratification Blood Test
THE ROLE OF INFORMATION TECHNOLOGY
- Table 2-11: Selected Laboratory Information Management System Providers, 2024 Vendor List
INDUSTRY DRIVERS
- Global Demographics
  - Table 2-12: The Global Population, 1980-2060 (millions)
  - Figure 2-11: The Global Population, 1980-2060 (millions)
- Regional Population Overview
  - Table 2-13: World Population by UN Defined Geographic Region, 2010-2060 (millions)
  - Figure 2-12: World Population by UN Defined Geographic Region, 2010-2060 (millions)
- Aging Populations
  - Table 2-14: Global Population Trends Age 65+, 2000-2060 (millions)
  - Figure 2-13: Global Population Trends Age 65+, 2000-2060 (millions)
- Chronic Diseases and Conditions
  - Figure 2-14: Global Prevalence of Disease, 2000, 2015, and Projected 2030
  - Figure 2-15: Leading Causes of Death Globally, by Number of Deaths, 2021 (millions)
- Economic Performance
- Health Expenditures
  - Figure 2-16: Global Health Spending as a Percentage of GDP, by Country, 2023 estimates (%) (Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, the Netherlands, Poland, Russia, South Korea, Saudi Arabia, South Africa, Spain, Turkey, United Kingdom, United States)
- Laboratory Performance Drivers and Challenges
- Drivers
- Challenges

CHAPTER THREE: TESTING SERVICES BY SPECIALTY

TEST AND SERVICES OVERVIEW
- Figure 3-1: Global Clinical Laboratory Market Analysis: Service Revenue Trend, 2019-2029 ($ million)
- Table 3-1: Global Clinical Laboratory Market Analysis, by Test Segment, 2019-2029 ($ million)* (Clinical Chemistry: Routine & Essential; COVID-19; Cytology & Histology; Genetic; Immunology & Microbiology; Toxicology)
- Figure 3-2: Global Clinical Laboratory Market Analysis, by Test Segment, 2019-2029 ($ million)* (Clinical Chemistry: Routine & Essential; COVID-19; Cytology & Histology; Genetic; Immunology & Microbiology; Toxicology)
- Figure 3-3: Global Clinical Laboratory Market Analysis, Segment Growth Forecast, CAGR 2024-2029 (%) (Clinical Chemistry: Routine & Essential; COVID-19; Cytology & Histology; Genetic; Immunology & Microbiology; Toxicology)
- Figure 3-4: Global Clinical Laboratory Market Analysis, by Testing Service, Distribution of Revenues, 2024 (%) (Clinical Chemistry: Routine & Essential; COVID-19; Cytology & Histology; Genetic; Immunology & Microbiology; Toxicology)
CLINICAL CHEMISTRY - ROUTINE AND ESSENTIAL TESTING
- Figure 3-5: Global Clinical Laboratory Market Analysis: Clinical Chemistry - Routine & Essential Testing Service Market Trend, 2019-2029 ($ million)
- Table 3-2: Market Overview - Routine and Essential Testing, by Service Segment, 2024 ($ million) (Clinical Chemistry, Coagulation, Endocrinology, Hematology, Others)
- Figure 3-6: Market Revenue - Routine and Essential Testing, by Service Segment, 2024 ($ million) (Clinical Chemistry, Coagulation, Endocrinology, Hematology, Others)
- Figure 3-7: Market Share - Routine and Essential Testing, by Service Segment, 2024 (%) (Clinical Chemistry, Coagulation, Endocrinology, Hematology, Others)
- Routine Clinical Chemistry
- Cholesterol Level Testing
  - Table 3-3: High Cholesterol Risk Categories
- Urinalysis
  - Table 3-4: Normal Reference Levels in a Medical Urinalysis
- Hematology
- Blood Cell Count
  - Table 3-5: Laboratory Reference Parameters for CBC
- Coagulation
- Endocrinology
- Thyroid Function Tests
- Pregnancy Testing
  - Table 3-6: hCG Levels in Pregnant Women by Days Past Ovulation
IMMUNOLOGY AND MICROBIOLOGY
- Figure 3-8: Global Clinical Laboratory Market Analysis: Immunology & Microbiology Testing Service Market Trend, 2019-2029 ($ million)
- Table 3-7: Market Overview - Immunology & Microbiology Testing, by Service Segment, 2024 ($ million) (Immunology, Infectious Disease)
- Figure 3-9: Market Revenue - Immunology & Microbiology Testing, by Service Segment, 2024 ($ million) (Immunology, Infectious Disease)
- Figure 3-10: Market Share - Immunology & Microbiology Testing, by Service Segment, 2024 ($ million) (Immunology, Infectious Disease)
- Allergy and Food Intolerance
- Tumor Markers
- Cardiac Markers
- HIV Testing
CYTOLOGY AND HISTOLOGY TESTING
- Figure 3-11: Global Clinical Laboratory Market Analysis: Cytology & Histology Testing Service Market Trend, 2019-2029 ($ million)
- Table 3-8: Market Overview - Cytology & Histology Testing, by Service Segment, 2024 ($ million) (HPV Testing (Routine/DNA), Tumor Pathology)
- Figure 3-12: Market Revenue - Cytology & Histology Testing, by Service Segment, 2024 ($ million) (HPV Testing (Routine/DNA), Tumor Pathology)
- Figure 3-13: Market Share - Cytology & Histology Testing, by Service Segment, 2024 ($ million) (HPV Testing (Routine/DNA), Tumor Pathology)
- Pap Test
  - Figure 3-14: Percent of Females Aged 20-69 Screened for Cervical Cancer (all screening methods), by Select Country, 2019 Estimates (%) (Canada, China, France, Germany, Hungary, India, Israel, Italy, Japan, The Netherlands, Poland, Romania, Saudi Arabia, South Africa, South Korea, Spain, Turkey, United Kingdom, United States)
  - Figure 3-15: Summary Recommendations: WHO Suggests Using the Following Strategy for Cervical Cancer Prevention, 2021
GENETIC TESTING
- Figure 3-16: Global Clinical Laboratory Market Analysis: Genetic Testing Service Market Trend, 2019-2029 ($ million)
- Table 3-9: Market Overview - Genetic Testing, by Service Segment, 2024 ($ million) (Prenatal/Newborn Screening, Other Genetic Screening)
- Figure 3-17: Market Revenue - Genetic Testing, by Service Segment, 2024 ($ million) (Prenatal/Newborn Screening, Other Genetic Screening)
- Figure 3-18: Market Share - Genetic Testing, by Service Segment, 2024 ($ million) (Prenatal/Newborn Screening, Other Genetic Screening)
TOXICOLOGY TESTING
- Figure 3-19: Global Clinical Laboratory Market Analysis: Toxicology Testing Service Market Trend, 2019-2029 ($ million)
- Table 3-10: Substance Detection Periods, by Selected Test Method

CHAPTER FOUR: GLOBAL CLINICAL LABORATORY MARKET BY PROVIDER GROUP

CLINICAL LABORATORY MARKET: PROVIDER OVERVIEW
- Table 4-1: Global Clinical Laboratory Market Analysis, by Provider Segment, 2024 and 2029 (Hospitals, Independent, Physician Offices/Outpatient Clinics)
- Figure 4-1: Global Clinical Laboratory Market Analysis: Provider Segment Growth Forecast, CAGR 2024-2029 (%) (Hospitals, Independent, Physician Offices/Outpatient Clinics)
- Figure 4-2: Global Clinical Laboratory Market Analysis by Provider Group, Distribution of Revenues, 2024 (%) (Hospitals, Independent, Physician Offices/Outpatient Clinics)
HOSPITALS AND ACUTE CARE PROVIDERS
- Figure 4-3: COVID-19 Impact on Hospital-based Laboratory Testing Markets, 2022-2024 ($ million)
- Table 4-2: Global Clinical Laboratory Market Analysis: Hospital and Acute Care Laboratory Testing Market, 2024-2029 ($ million) (U.S./International Estimates)
- Figure 4-4: Global Clinical Laboratory Market Analysis: Hospital and Acute Care Laboratory Testing Market, 2024-2029 ($ million) (U.S./International Estimates)
- Figure 4-5: Hospital Beds per 1,000 Population, by Country, 2023/2024 (Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, The Netherland, Poland, Russia, Saudi Arabia, South Africa, South Korea, Spain, Turkey, United Kingdom, United States)
- Figure 4-6: Global Visualization - Hospital Beds per 1,000 Population, by Country, 2023/2024
PHYSICIANS AND OUTPATIENT CARE PROVIDERS
- Figure 4-7: COVID-19 Impact on Physician-based Laboratory Testing Markets, 2022-2024 ($ million)
- Table 4-3: Global Clinical Laboratory Market Analysis: Physician and Outpatient Care Laboratory Testing Market, 2024-2029 ($ million) (U.S./International Estimates)
- Figure 4-8: Global Clinical Laboratory Market Analysis: Physician and Outpatient Care Laboratory Testing Market, 2024-2029 ($ million) (U.S./International Estimates)
- Physician Offices
  - Figure 4-9: Medical Doctors per 1,000 Population, by Country, 2023/2024 (Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, The Netherland, Poland, Russia, Saudi Arabia, South Africa, South Korea, Spain, Turkey, United Kingdom, United States)
  - Figure 4-10: Global Visualization - Medical Doctors per 1,000 Population, by Country, 2023/2024
- Global Nursing Establishments and Assisted Living Facilities
- Global Dialysis Clinics
INDEPENDENT LABORATORY PROVIDERS
- Figure 4-11: COVID-19 Impact on Independent Laboratory Testing Markets, 2022-2024 ($ million)
- Table 4-4: Revenues for Selected U.S.-based Reference Labs, 2019-2024 ($ million)* (Bio-Reference Lab/OPKO, Labcorp, Quest Diagnostics)
- Table 4-5: Estimated Clinical Test Volume, by Select Independent Laboratory, 2024 (millions of units) (Bio-Reference Lab/Opko, Eurofins Scientific, Labcorp, Medicover, Natera, NeoGenomics, Quest Diagnostics, Sonic Healthcare, Unilabs)
- Table 4-6: Global Clinical Laboratory Market Analysis: Independent Laboratory Testing Market, 2024-2029 ($ million) (U.S./International Estimates)
- Figure 4-12: Global Clinical Laboratory Market Analysis: Independent Laboratory Testing Market, 2024-2029 ($ million) (U.S./International Estimates)

CHAPTER FIVE: NORTH AMERICA MARKET

OVERVIEW
- Table 5-1: North America Market Value, by Country, 2024 ($ million)* (United States, Canada & other regions)
- Figure 5-1: North America Clinical Laboratory Service Revenues, by Country, 2024-2029 ($ million)* (Canada and United States)
- Figure 5-2: North America Clinical Laboratory Service Share, by Country, 2024 (%) (United States, Canada & other regions)
UNITED STATES
- Table 5-2: United States Clinical Laboratory Service Market, Estimates and Forecast 2024 and 2029 ($ million)
- Figure 5-3: United States Clinical Laboratory Service Market Performance, 2019-2029 ($ million)
- U.S. Market by Test Type
  - Table 5-3: United States Clinical Laboratory Service Market, by Testing Service Type, Estimates and Forecast 2024-2029 ($ million) (COVID-19, Cytology & Pathology, Essential & Routine, Genetic, Immunology & Microbiology, Toxicology)
  - Figure 5-4: United States Clinical Laboratory Market Analysis: Testing Service Revenues Over Time, by Testing Service Type, 2019-2029 ($ million) (COVID-19, Cytology & Pathology, Essential & Routine, Genetic, Immunology & Microbiology, Toxicology)
  - Figure 5-5: United States Clinical Laboratory Market Analysis: Testing Service Revenue Share, by Testing Service Type, 2024 ($ million) (COVID-19, Cytology & Pathology, Essential & Routine, Genetic, Immunology & Microbiology, Toxicology)
- U.S. Market by Laboratory Provider Type
  - Table 5-4: United States Clinical Laboratory Service Market, by Laboratory Type, Estimates and Forecast 2024-2029 ($ million) (Hospital-based, Independent, Physician-based)
  - Figure 5-6: United States Clinical Laboratory Market Analysis: Testing Service Revenues Over Time, by Laboratory Type, 2019-2029 ($ million) (Hospital-based, Independent, Physician-based)
  - Figure 5-7: United States Clinical Laboratory Market Share, by Laboratory Type, 2024 (%) (Hospital-based, Independent, Physician-based)
- U.S. Clinical Laboratory Industry Structure
  - Figure 5-8: Growth in Clinical Laboratories, 2000-2024
CLIA Laboratory Registration, Laboratories by Type
- Figure 5-9: U.S. CLIA Clinical Laboratory Registration, by Primary Laboratory Type, May 2024
- Table 5-5: CLIA Registered Laboratories, by Type of Facility (Exempt/Non-Exempt Combined), May 2024
- Figure 5-10: Growth Trends in CLIA Registered Laboratories, by Type of Facility (Exempt/Non-Exempt Combined) June 2020 and May 2024
- Figure 5-11: Percent Change in CLIA Registered Laboratories by Type of Facility, Highest and Lowest Growth Segments, Compounded Annually, 2020-2024 (%)
- Independent Clinical Laboratories
  - Figure 5-12: Leading U.S. Independent Laboratory Groups, Distribution of Centers, December 2024 (%)
- Growth in Independent Clinical Laboratories
  - Figure 5-13: Growth in U.S. Independent Laboratory Facilities, June 2011 through April 2024
- Hospital-based Laboratories
U.S. Hospital Data
- Table 5-6: U.S. Hospital Types
- Table 5-7: AHA Statistics - U.S. Registered Hospitals, by Type, 2010-2023
- Table 5-8: AHA Statistics for U.S. Hospitals, 2014-2023
- U.S. Hospital Stay Stats
  - Figure 5-14: U.S. Hospital Length of Stay, Average by Broad Age Group, 2021 (# days of hospital stay)
- Growth in Hospital Clinical Laboratories
  - Figure 5-15: Growth in U.S. Hospital Laboratory Locations, June 2011-April 2024
- Physician-Office and Clinic Laboratories
- Number of U.S. Physicians
- Growth in Clinical Laboratories in Physician Offices
  - Figure 5-16: Growth in U.S. Physician Office Laboratory Locations, June 2011-April 2024
- Nursing Facility and Home Health
- U.S. Nursing Home Establishments
- U.S. Home Health Facilities
- Growth in Clinical Laboratories in the Nursing Facility and Home Health Segment
  - Figure 5-17: Growth in U.S. Nursing Facility/Home Health Laboratory Locations, June 2011-April 2024
- Pharmacy-based Laboratories
- Growth in Pharmacy-Based Clinical Laboratories
  - Figure 5-18: Growth in U.S. Pharmacy-Based Laboratories, mid-2011-April 2024
- Dialysis Clinics
- Growth in U.S. Dialysis Clinics and Affiliated Laboratories
  - Figure 5-19: Growth in U.S. Dialysis Clinic-based Laboratories, mid-2011-April 2024
CANADA
- Table 5-9: Canada Clinical Laboratory Service Market, Estimates and Forecast 2024 and 2029 ($ million)
- Figure 5-20: Canada Clinical Laboratory Service Market, Performance 2019-2029 ($ million)

CHAPTER SIX: EUROPE, THE MIDDLE EAST, AND AFRICA (EMEA) MARKET

OVERVIEW
- Table 6-1: EMEA Market Value, by Country, 2024 ($ million)* (France, Germany, Italy, Spain, Switzerland, United Kingdom, Rest of EMEA)
- Figure 6-1: EMEA Clinical Laboratory Service Market Value, by Country, 2024-2029 ($ million)* (France, Germany, Italy, Spain, Switzerland, United Kingdom)
- Figure 6-2: EMEA Clinical Laboratory Service Market Share, by Country, 2024 (%) (France, Germany, Italy, Spain, Switzerland, United Kingdom, Rest of EMEA)
- Figure 6-3: EMEA Clinical Laboratory Service Market, Growth Projections by Country, CAGR 2024-2029 (%) (France, Germany, Italy, Spain, Switzerland, United Kingdom, Rest of EMEA)
KEY MARKETS
- Germany
  - Table 6-2: Germany Clinical Laboratory Service Market, Estimates and Forecast 2024-2029 ($ million)
  - Figure 6-4: Leading Laboratory Service Suppliers, by Estimated Distribution of Revenues, Germany, 2024 (%) (Eurofins, IMD - Medicover, Siemens, Sonic, SYNLAB, Others)
- France
  - Table 6-3: France Clinical Laboratory Service Market, Estimates and Forecast 2024 and 2029 ($ million)
- Italy
  - Table 6-4: Italy Clinical Laboratory Service Market, Estimates and Forecast 2024 and 2029 ($ million)
- Spain
  - Table 6-5: Spain Clinical Laboratory Service Market, Estimates and Forecast 2024 and 2029 ($ million)
- United Kingdom
  - Table 6-6: United Kingdom Clinical Laboratory Service Market, Estimates and Forecast 2024 and 2029 ($ million)
- Switzerland
  - Table 6-7: Switzerland Clinical Laboratory Service Market, Estimates and Forecast 2024 and 2029 ($ million)

CHAPTER SEVEN: ASIA PACIFIC (APAC) MARKET

OVERVIEW
- Table 7-1: Asia Pacific Clinical Laboratory Service Market Value, by Country, 2024 ($ million) (Australia, China, India, Japan, South Korea, Rest of Asia Pacific)
- Figure 7-1: Asia Pacific Clinical Laboratory Service Market Value, by Country, 2024-2029 ($ million)* (Australia, China, India, Japan, South Korea, Rest of Asia Pacific)
- Figure 7-2: Asia Pacific Clinical Laboratory Service Market Share, by Country, 2024 (%) (Australia, China, India, Japan, South Korea, Rest of Asia Pacific)
- Figure 7-3: Asia Pacific Clinical Laboratory Service Market, Growth Projections by Country, CAGR 2024-2029 (%) (Australia, China, India, Japan, South Korea, Rest of Asia Pacific)
KEY COUNTRIES
- Japan
  - Table 7-2: Japan Clinical Laboratory Service Market, Estimates and Forecast 2024 and 2029 ($ million)
- Japan Clinical Laboratory Industry Structure
  - Figure 7-4: Japan Clinical Laboratory Industry, by Type, 2024 (%)
  - Figure 7-5: Japan Clinical Laboratory Industry, by Test Classification, 2023-2024 (%) (Basic (essential/routine), Non-Basic, Pathology, Other Test Services)
  - Figure 7-6: Japan Clinical Laboratory Industry, Number of Laboratories by Prefecture, 2024 (%)
- China
  - Table 7-3: China Clinical Laboratory Service Market, Estimates and Forecast 2024 and 2029 ($ million)
- China Clinical Laboratory Industry Structure
  - Figure 7-7: China Clinical Laboratory Industry, by Type, 2024 (%)
- India
  - Table 7-4: India Clinical Laboratory Service Market, Estimates and Forecast 2024 and 2029 ($ million)
- Australia
  - Table 7-5: Australia Clinical Laboratory Service Market, Estimates and Forecast 2024 and 2029 ($ million)
- South Korea
  - Table 7-6: South Korea Clinical Laboratory Service Market, Estimates and Forecast 2024 and 2029 ($ million)

CHAPTER EIGHT: LATIN AMERICA MARKET

OVERVIEW
- Table 8-1: Latin America Clinical Laboratory Service Market Value, by Country, 2024 ($ million) (Brazil, Mexico, Rest of Latin America)
- Figure 8-1: Latin America Clinical Laboratory Service Market Value, by Country, 2024-2029 ($ million)* (Brazil, Mexico, Rest of Latin America)
- Figure 8-2: Latin America Clinical Laboratory Service Market Share, by Country, 2024 (%) (Brazil, Mexico, Rest of Latin America)
- Figure 8-3: Latin America Clinical Laboratory Service Market, Growth Projections, by Country, CAGR 2024-2029 (%) (Brazil, Mexico, Rest of Latin America)
KEY COUNTRIES
- Brazil
  - Table 8-2: Brazil Clinical Laboratory Service Market, Estimates and Forecast 2024 and 2029 ($ million)
- Mexico
  - Table 8-3: Mexico Clinical Laboratory Service Market, Estimates and Forecast 2024 and 2029 ($ million)

CHAPTER NINE: LEADING MARKET PARTICIPANTS

GLOBAL COMPETITOR SUMMARY
- Figure 9-1: Market Participants, Global Service Revenues, Estimated 2023 and 2024 ($ million)
- U.S. COMPETITIVE ANALYSIS
  - Table 9-1: Top Ten Estimated U.S. Laboratory Service Revenues ($ million) and Market Share (%) of Leading Clinical Laboratory Providers, 2024
  - Figure 9-2: Top 10 Estimated U.S. Laboratory Services, Market Share of Leading Clinical Laboratory Providers, 2024 (%)
SELECT COMPANY PROFILES
ARUP LABORATORIES
- Company Overview
  - Table 9-2: ARUP Corporate Details
- Key Acquisitions, Alliances, and Partnerships
- Products and Services
BIOREFERENCE HEALTH - AN OPKO HEALTH SUBSIDIARY
- Company Overview
  - Table 9-3: BioReference Health Corporate Details
- Key Acquisitions, Alliances, and Partnerships
- Products and Services
DAVITA
- Company Overview
  - Table 9-4: DaVita Corporate Details
- Products and Services
EUROFINS SCIENTIFIC SE
- Company Overview
  - Table 9-5: Eurofins Scientific Corporate Details
- Key Acquisitions, Alliances, and Partnerships
- Products and Services
EXACT SCIENCES CORP.
- Company Overview
  - Table 9-6: Exact Sciences Corporate Details
- Key Acquisitions, Alliances, and Partnerships
- Products and Services
GUARDANT HEALTH
- Company Overview
  - Table 9-7: Guardant Health Corporate Details
- Key Acquisitions, Alliances, and Partnerships
- Products and Services
H.U. GROUP HOLDINGS
- Company Overview
  - Table 9-8: H.U. Group Holdings, Inc. Corporate Details
- Key Acquisitions, Alliances, and Partnerships
- Products and Services
LABORATORY CORPORATION OF AMERICA
- Company Overview
  - Table 9-9: Laboratory Corporation of America Corporate Details
- Key Acquisitions, Alliances, and Partnerships
- Products and Services
MEDICOVER AB
- Company Overview
  - Table 9-10: Medicover Corporate Details
- Key Acquisitions, Alliances, and Partnerships
- Products and Services
MYRIAD GENETICS, INC.
- Company Overview
  - Table 9-11: Myriad Genetics Corporate Details
- Key Acquisitions, Alliances, and Partnerships
- Products and Services
NATERA
- Company Overview
  - Table 9-12: Natera Corporate Details
- Key Acquisitions, Alliances, and Partnerships
- Products and Services
QUEST DIAGNOSTICS, INC.
- Company Overview
  - Table 9-13: Quest Diagnostics Corporate Details
- Key Acquisitions, Alliances, and Partnerships
- Products and Services
SIEMENS HEALTHINEERS
- Company Overview
  - Table 9-14: Siemens Healthineers Corporate Details
- Key Acquisitions, Alliances, and Partnerships
- Products and Services
SONIC HEALTHCARE LIMITED
- Company Overview
  - Table 9-15: Sonic Healthcare Corporate Details
- Key Acquisitions, Alliances, and Partnerships
- Products and Services
SYNLAB INTERNATIONAL GMBH
- Company Overview
  - Table 9-16: SYNLAB Corporate Details
- Key Acquisitions, Alliances, and Partnerships
- Products and Services
UNILABS
- Company Overview
  - Table 9-17: Unilabs Corporate Details
- Products and Services

CHAPTER TEN: MARKET TRENDS AND SUMMARY

GLOBAL MARKET OVERVIEW
- Table 10-1: Global Clinical Laboratory Market Analysis, 2019-2029 ($ million)*
- Figure 10-1: Global Clinical Laboratory Market Analysis, 2019-2029 ($ million)
REGIONAL OVERVIEW
- Table 10-2: Global Clinical Laboratory Service Market Analysis, Revenues by Region, 2024 ($ million) (Asia Pacific, EMEA, Latin America, North America)
- Figure 10-2: Global Clinical Laboratory Service Market Analysis, Revenues by Region, 2024 ($ million) (Asia Pacific, EMEA, Latin America, North America)
- Figure 10-3: Global Clinical Laboratory Service Market Share, Revenues by Region, 2024 (%) (Asia Pacific, EMEA, Latin America, North America)
- Figure 10-4: Global Clinical Laboratory Market Analysis: Regional Growth Forecast, CAGR 2024-2029 (%) (Asia Pacific, EMEA, Latin America, North America)
- Population Growth
- Aging Populations
- Increasing Disease Burden
- Economic Growth in Developing Regions
- Stabilizing Economies in Developed Regions
- Pricing Pressures
- Focus on Efficient Health Systems
- Overall Growth in Demand for Healthcare Services
- COVID-19
- Multiplex Testing
- AI and Machine Learning Laboratory Trends
- Molecular Testing and Other Advanced Testing Will Open New Avenues
- Digital Pathology Trends
- Staffing Shortages